Briefcases -- Drugs -- VALSARTAN (amlodipine) by Mylan Pharmaceuticals, Inc., et al.

VALSARTAN (amlodipine) by Mylan Pharmaceuticals, Inc., et al.

Case Files
News
Committees
Request a Document
Request
Search Within Briefcase

Folders

  1. Evidentiary and Research Documents
    1. Single Event Case Filings
    2. Media References
    3. FDA Regulatory Materials

Quick Access

  1. VALSARTAN Products Recall List (December 4, 2018)
  2. VALSARTAN (Gremillion) Complaint v. Zhejiang Huahai Pharmaceutical Co., Ltd., et al., USDC WD of Louisiana (Lafayette) (November 15, 2018)
  3. VALSARTAN (Jones) Complaint v. Zhejiang Huahai Pharmaceutical Co., Ltd., et al., USDC ED Missouri (Eastern) (September 11, 2018)
  4. VALSARTAN (Neal) Class-Action Complaint v. Zhejiang Huahai Pharmaceutical Co., Ltd., et al., USDC New Jersey (November 12, 2018)
  5. VALSARTAN (Roberts) Class-Action Complaint v. Zhejiang Huahai Pharmaceutical Co., Ltd., et al., USDC New Jersey (November 12, 2018)
  6. More Blood Pressure Meds Recalled Due to Carcinogen by HealthDay News (December 7, 2018)
  7. FDA Warning Letter to Zheziang Huahai Pharmaceutical Co., Ltd. (November 29, 2018)